NasdaqGS:VTRSPharmaceuticals
Assessing Viatris (VTRS) Valuation As Investor Event Outlines Long Term Plans Through 2030
Viatris (VTRS) has drawn fresh attention after announcing an Investor Event where leaders plan to lay out the company’s vision through 2030, including growth drivers, pipeline plans, portfolio choices, and capital return priorities.
See our latest analysis for Viatris.
Viatris shares currently trade at US$13.20, with a 30-day share price return of 17.76% decline, a 90-day share price return of 10.65%, and a 1-year total shareholder return of 50.99%.
If the Investor Event has you thinking...